EPMT Reduces Subsidiary Capital, Focuses on Strengthening Group Efficiency
Jakarta, TopBusiness – PT Enseval Putera Megatrading Tbk (IDX: EPMT) has carried out an adjustment to the capital structure of its subsidiary, PT Mitra Ananda Megadistrindo (MAM).
The company affirmed that the corporate action forms part of a restructuring of the group’s investment structure and has no material impact on operational activities or the company’s financial condition.
According to a disclosure submitted to the Indonesia Stock Exchange (IDX), EPMT reduced the issued and paid-up capital of PT Mitra Ananda Megadistrindo (MAM) as part of efforts to optimise the group’s capital structure.
Sugianto, Corporate Secretary of PT Enseval Putera Megatrading Tbk, explained that the step was taken to adjust the capital requirements of the subsidiary without changing the company’s control over MAM.
“The capital reduction at PT Mitra Ananda Megadistrindo was carried out as part of the adjustment of the group’s capital structure. This transaction has no material impact on the company’s operational activities, financial condition, or business continuity,” Sugianto said in the disclosure on Tuesday (21 July 2026).
The company explained that the capital reduction was carried out in accordance with prevailing laws and regulations and has obtained approval from the shareholders of PT Mitra Ananda Megadistrindo.
Management also assured that the corporate action does not change MAM’s status as a subsidiary or the company’s control structure over the firm. Consequently, MAM’s operations continue as usual.
According to the company, the move forms part of investment management aimed at creating a more efficient capital structure that suits the group’s business needs.
“The company ensures this transaction does not create any negative impact on operational, legal or financial aspects, nor on the company’s business continuity,” Sugianto said.
In the disclosure, EPMT also stated that the capital reduction transaction at MAM does not constitute a Material Transaction or an Affiliated Transaction involving a Conflict of Interest as regulated under the rules of the Financial Services Authority (OJK).
As a company engaged in the distribution of healthcare products, pharmaceuticals, medical devices and consumer goods, Enseval periodically evaluates the investment structure of its subsidiaries to support efficient group management and strengthen long-term business fundamentals.
Management therefore views the corporate action as largely administrative and strategic in nature, aimed at strengthening governance of the group’s capital structure while ensuring the company retains flexibility to support future business development.